$949.8 K

CGNH Mkt cap, 30-Oct-2017
CardioGenics Net income (FY, 2015)-1.9 M
CardioGenics EBIT (FY, 2015)-772.1 K
CardioGenics Cash, 31-Oct-201549.9 K

CardioGenics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015

General and administrative expense

1.9m451.5k541.6k

Operating expense total

1.9m451.5k541.6k

EBIT

(2.5m)(973.5k)(772.1k)

Net Income

(2.9m)(2.7m)(1.9m)

CardioGenics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015

Cash

263.1k70.7k49.9k

Accounts Receivable

246.0228.0

Current Assets

52.3k

PP&E

53.5k42.7k35.2k

Total Assets

548.0k269.9k

Accounts Payable

1.1m1.0m1.2m

Current Liabilities

1.4m

Additional Paid-in Capital

44.5m46.5m47.8m

Retained Earnings

(49.6m)

CardioGenics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015

Net Income

(2.9m)(2.7m)(1.9m)

Depreciation and Amortization

10.8k7.5k

Accounts Receivable

191.0

Accounts Payable

418.6k183.9k223.6k

Cash From Operating Activities

(718.6k)(597.1k)(606.6k)

Purchases of PP&E

(153.0)

Cash From Investing Activities

(15.8k)(2.1k)

Cash From Financing Activities

932.4k396.1k364.6k